Advantage Therapeutics
Business Services · Florida, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
195 NW 40th St, Miami, Florida, 33127, U...Revenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Advantage Therapeutics
ADvantage Therapeutics is focused on developing novel immunotherapies for early Alzheimer's Disease (AD) and other neurodegenerative conditions. The company is currently approved for Phase 2 clinical trials in Europe and aims to provide disease-modifying treatments that improve patient outcomes. With a dedicated research team based at the Vienna BioCenter, ADvantage Therapeutics is committed to innovative approaches that challenge conventional assumptions in Alzheimer's research. Their lead therapeutic, AD04, has shown promising results in clinical trials, indicating potential benefits for patients suffering from early-stage Alzheimer's.Explore more
Popular SearchesAdvantage TherapeuticsSIC Code 87,873NAICS Code 54,541Show moreAdvantage Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Advantage Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Advantage Therapeutics is spiking on competitors!
Product Launch: Get notified when Advantage Therapeutics launches new products
Click to see if Advantage Therapeutics had a recent Job posting/layoffs
Earning: See what the market has to say on Advantage Therapeutics recently announced quarterly report
Advantage Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Advantage Therapeutics
Funding: Get notified immidiatlly once Advantage Therapeutics has new funding data
Check if Advantage Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined Advantage Therapeutics as Masked Content
Find 3 more new buyers
Advantage Therapeutics Tech Stack
A closer look at the technologies used by Advantage Therapeutics
See more technologies
Advantage Therapeutics News & Media
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Advantage Therapeutics
Sign Up For FreeTo access detailed company insights
ADvantage Therapeutics is focused on developing novel immunotherapies for early Alzheimer's Disease (AD) and other neurodegenerative conditions. The company is currently approved for Phase 2 clinical trials in Europe and aims to provide disease-modifying treatments that improve patient outcomes. With a dedicated research team based at the Vienna Bi... Read More
